Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-20 Purchase | 2024-08-21 4:32 pm | EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director | 2,567 | $7.79 | $19,997 | 9,967 (Direct) | View |
| 2024-08-21 Purchase | 2024-08-21 4:01 pm | EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director | 5,000 | $7.95 | $39,750 | 13,150 (Direct) | View |
| 2024-08-19 Purchase | 2024-08-21 4:01 pm | EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director | 12,500 | $7.98 | $99,750 | 16,500 (Direct) | View |
| 2024-08-16 Purchase | 2024-08-20 4:04 pm | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 3,173 | $7.88 | $25,003 | 224,524 (Indirect Direct) | View |
| 2024-07-12 Sale | 2024-07-16 4:24 pm | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 11,625 | $10.06 | $116,995 | 11,625 (Direct) | View |
| 2024-06-03 Sale | 2024-06-04 4:28 pm | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 11,625 | $10.3 | $119,705 | 23,250 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 5:19 pm | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 11,625 | $12.65 | $147,045 | 34,875 (Direct) | View |
| 2024-05-06 Purchase | 2024-05-08 4:23 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 850,000 | $11.86 | $10,081,721 | 8,325,000 (Indirect) | View |
| 2024-04-18 Purchase | 2024-04-22 4:00 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 581,765 | $18.03 | $10,489,446 | 7,475,000 (Indirect) | View |
| 2024-02-02 Sale | 2024-02-05 5:15 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 209 | $28.49 | $5,954 | 42,337 (Direct) | View |
| 2024-01-26 Sale | 2024-01-30 4:53 pm | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 49,325 | $25.66 | $1,265,539 | 106,372 (Direct) | View |
| 2024-01-26 Sale | 2024-01-29 5:54 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 26,017 | $25.38 | $660,370 | 115,425 (Direct) | View |
| 2024-01-25 Sale | 2024-01-29 5:51 pm | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 600 | $25 | $15,000 | 104,444 (Direct) | View |
| 2024-01-24 Sale | 2024-01-26 5:03 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 11,900 | $25.01 | $297,621 | 245,522 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 6:26 pm | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 16,386 | $25.01 | $409,790 | 184,834 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 6:24 pm | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 35,000 | $24.98 | $874,200 | 638,449 (Indirect Direct) | View |
| 2024-01-22 Sale | 2024-01-24 4:50 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 35,066 | $22.68 | $795,191 | 189,176 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:55 pm | EyePoint Pharmaceuticals Inc. | EYEP | Ocumension Therapeutics Director | 1,910,500 | $19.45 | $37,159,225 | 100,221 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:01 pm | EyePoint Pharmaceuticals Inc. | EYPT | Liu Ye Director | 1,910,500 | $19.45 | $37,159,225 | 100,221 (Indirect) | View |
| 2024-01-09 Purchase | 2024-01-11 4:00 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 855,000 | $19.94 | $17,051,100 | 6,893,235 (Indirect) | View |
| 2024-01-08 Sale | 2024-01-10 4:53 pm | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 22,913 | $21.13 | $484,124 | 105,247 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-03 Option Award | 2024-09-05 4:02 pm | N/A 2034-09-03 | EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-07-26 Gift | 2024-07-26 4:47 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 262,574 | $0 | 1,045,966 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-16 4:24 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 3,250 | $3.5 | 11,625 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-16 4:24 pm | 2024-02-23 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 9,775 | $0 | 11,625 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-16 4:24 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 6,525 | $3.26 | 11,625 (Direct) | View |
| 2024-07-10 Tax Withholding | 2024-07-12 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 8,059 | $8.69 | 93,861 (Direct) | View |
| 2024-07-10 Exercise | 2024-07-12 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 16,666 | $0 | 93,861 (Direct) | View |
| 2024-07-10 Exercise | 2024-07-12 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 11,111 | $0 | 243,574 (Direct) | View |
| 2024-07-11 Exercise | 2024-07-12 5:00 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director | 2,000 | $0 | 6,000 (Direct) | View |
| 2024-06-23 Exercise | 2024-06-25 4:16 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | ADAMIS ANTHONY P Director | 2,000 | $0 | 6,000 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 4:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 3,250 | $3.5 | 23,250 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 4:28 pm | 2024-02-23 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 9,775 | $0 | 23,250 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 4:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 6,525 | $3.26 | 23,250 (Direct) | View |
| 2024-05-25 Tax Withholding | 2024-05-28 4:22 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 3,627 | $11.16 | 62,480 (Direct) | View |
| 2024-05-25 Exercise | 2024-05-28 4:22 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 7,500 | $0 | 62,480 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 3,250 | $3.5 | 34,875 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:19 pm | 2024-02-23 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 9,775 | $0 | 34,875 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 6,525 | $3.26 | 34,875 (Direct) | View |
Ownership | 2024-04-22 4:15 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Adage Capital Management L.P. Atchinson Robert Gross Phillip 10% Owner | 0 | $0 | 5,156,299 (Indirect) | View |
| 2024-03-30 Tax Withholding | 2024-04-02 5:27 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 25,546 | $20.67 | 67,080 (Direct) | View |
| 2024-03-30 Exercise | 2024-04-02 5:27 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 50,404 | $0 | 67,080 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:40 pm | N/A 2034-03-01 | EyePoint Pharmaceuticals Inc. | EYPT | Ribeiro Ramiro Chief Medical Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-02-27 Gift | 2024-02-28 4:46 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 2,500 | $0 | 51,920 (Direct) | View |
| 2024-02-20 Gift | 2024-02-22 5:08 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 20,000 | $0 | 51,920 (Direct) | View |
| 2024-02-13 Gift | 2024-02-13 5:40 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 99,817 | $0 | 758,740 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:40 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 14,943 | $28.8 | 758,740 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 5:40 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 37,534 | $0 | 758,740 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:39 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 5,083 | $28.8 | 48,056 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 5:39 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 10,800 | $0 | 48,056 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:38 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 3,656 | $28.8 | 49,916 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 5:38 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 9,967 | $0 | 49,916 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:38 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 3,192 | $28.8 | 49,441 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 5:38 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 10,800 | $0 | 49,441 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:37 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 3,533 | $28.8 | 58,920 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 5:37 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 11,967 | $0 | 58,920 (Direct) | View |
| 2024-02-02 Exercise | 2024-02-05 5:15 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 209 | $11.47 | 42,337 (Direct) | View |
| 2024-02-02 Exercise | 2024-02-05 5:15 pm | N/A 2031-11-01 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 209 | $0 | 42,337 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-30 4:53 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 15,609 | $12.9 | 106,372 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-30 4:53 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 33,716 | $13.13 | 106,372 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-30 4:53 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 49,325 | $0 | 106,372 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-29 5:54 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 9,604 | $12.9 | 115,425 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-29 5:54 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 26,017 | $0 | 115,425 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-29 5:54 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 16,413 | $3.26 | 115,425 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 5:51 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 300 | $12.9 | 104,444 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 5:51 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 300 | $13.13 | 104,444 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 5:51 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 600 | $0 | 104,444 (Direct) | View |
| 2024-01-24 Exercise | 2024-01-26 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 5,900 | $12.9 | 245,522 (Direct) | View |
| 2024-01-24 Exercise | 2024-01-26 5:03 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 11,900 | $0 | 245,522 (Direct) | View |
| 2024-01-24 Exercise | 2024-01-26 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 6,000 | $3.26 | 245,522 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-25 6:26 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 7,690 | $12.9 | 184,834 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-25 6:26 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 8,696 | $13.13 | 184,834 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-25 6:26 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 16,386 | $0 | 184,834 (Direct) | View |
| 2024-01-24 Gift | 2024-01-25 6:24 pm | N/A 2033-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 225,400 | $0 | 638,449 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 400 | $12.9 | 189,176 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 28,750 | $10.13 | 189,176 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 5,416 | $11.47 | 189,176 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 4:50 pm | N/A 2031-11-01 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 35,066 | $0 | 189,176 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 500 | $3.26 | 189,176 (Direct) | View |
| 2024-01-08 Exercise | 2024-01-10 4:53 pm | N/A 2033-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 22,913 | $0 | 105,247 (Direct) | View |
| 2024-01-08 Exercise | 2024-01-10 4:53 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 22,913 | $3.26 | 105,247 (Direct) | View |